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Background and purpose   There have been numerous reports of 
animal models of osteomyelitis. Very few of these have been pros-
thesis models that imitate human conditions. We have developed 
a  new  rat  model  of  implant-related  osteomyelitis  that  mimics 
human  osteomyelitis,  to  investigate  the  pathology  of  infection 
after orthop edic implant surgery.
Methods   2 wild-type strains of Staphylococcus aureus, MN8 
and UAMS-1, and their corresponding mutants that are unable 
to  produce  poly-N-acetyl  glucosamine  (PNAG)  (ica::tet)  were 
injected into the medullary canals of the femur and tibia at 3 dif-
ferent doses: 102, 103, and > 104 CFU/rat. We measured clinical 
signs, inflammatory markers, radiographic signs, histopathology, 
and bacteriology in the infected animals. 
Results   An inoculum of at least 104 cfu of either wild-type bac-
terial strain resulted in histological, bacteriological, and radio-
graphic signs of osteomyelitis with loosening of the prosthesis. An 
inoculum of 103 CFU gave signs of osteomyelitis but the prosthe-
sis remained in situ. Bacterial inocula of 102 cfu gave no signs of 
osteolysis.
Interpretation      We  have  established  a  new  knee  prosthe-
sis model that is suitable for reliable induction of experimental 
implant-associated osteomyelitis with the prosthesis in situ, using 
a small inoculum of S. aureus. At a dose of 103 CFU/rat, bacteria 
unable to produce PNAG (ica::tet) had only minor defects in their 
virulence.

Infections associated with in-dwelling orthopedic devices can 
be difficult to cure without removing the device, and they are 
quite expensive to manage (Darouiche 2004). Usual infection-
control measures, laminair air flow, and use of systemic anti-
microbial prophylaxis have not completely eliminated ortho-
pedic implant-related infections (Darouiche 2003). Staphylo-
coccus aureus is the predominant bacterium associated with 
infected metal implants (Eron 1985). There is an urgent need 
to  explore  other  approaches  to  enhance  diagnosis,  preven-
tion and treatment of infection, and osteomyelitis—for which 
appropriate animal models are extremely useful (Monzón et 
al. 2002). The aim of the present study was to establish an 
implant model of acute osteomyelitis associated with metal-
lic implants without any promoters of infection other than the 
implant itself.
Materials and methods 
S. aureus strains and bacterial challenge (Table 1)
We used the MN8 strain of S. aureus, originally obtained 
from a patient with toxic shock syndrome-1 (TSST-1), and 
the genetically related UAMS-1 strain of S. aureus, a primary 
isolate from a patient admitted to the Arkansas Children’s 
Hospital with an osteoarticular and soft-tissue infection and 
septic shock (Lucke et al. 2003, Cassat et al. 2006). UAMS-1 
is a clinical isolate from osteomyelitis and is therefore clearly 
relevant  to  the  model.  Strain  MN8  is  closely  related  to 
UAMS-1 genetically: both belong to the EMRSA-16 group 
of S. aureus, which are characterized by an identical mutation 
in the alpha-toxin gene that results in loss of production of 
this factor. ica-deficient strains were used to evaluate the role 
of PNAG antigen, which is synthesized by proteins encoded 
at the ica locus (Cramton et al. 1999), to determine whether 
it is a dominant feature of implant-related infections caused 
by S. aureus. To date, 100% of over 100 clinical isolates from 
all sources tested have been found to express poly-N-acetyl 
glucosamine (PNAG), which contributes to this organism’s 
ability to make biofilms. Biofilms are thought to be a major 
component of the pathogenesis of implant-related infections. Acta Orthopaedica 2013; 84 (1): 92–97  93
Thus, PNAG may be a virulence factor in implant infections 
and is a known target for immunotherapy and vaccination.
 41 rats were infected with 2 wild-type strains of S. aureus 
MN8 or UAMS-1, both of which are ica-positive, using inocu-
lating doses of bacteria of 105, 104, 103, or 102 CFU/rat (MN8: 
n = 23; UAMS-1: n = 18). There were at least 3 rats in each 
challenge group. 
Viable counts were done on the different bacterial strains to 
determine the exact dose inoculated. Both strains were also 
tested using mutants with deleted ica genes (ica::tet), which 
are referred to as ica-negative strains, at an infecting dose of 
103 CFU/rat with four rats in each group (Cramton et al. 1999, 
Beenken et al. 2004, Kropec et al. 2005). 5 rats were followed 
without being infected (the control group). The animal s were 
followed for 2–6 weeks and then killed. 
 
Anesthesia 
All rats were sedated with a subcutaneous injection of hypnorm/
dormicum, 0.3 mL/100 g body weight, given preoperatively 
and reinjected every 15 min (0.15 mL/100 g). After the opera-
tion, a femoralis block of the operated extremity was placed 
below the inguinal ligament using 1% lidocain/0.5% bupiva-
cain in 1 mL. The rats were killed with an intracardiac injec-
tion of 2 mL pentobarbital (200 mg/mL).
Surgery
We used 54 Sprague-Dawley male rats that were 7–9 weeks-
old (Taconic Europe) and weighing about 300 g. The experi-
ments  were  approved  by  the Animal  Ethics  Committee  of 
Denmark (reg. no. 2005/561-1049 from September 19, 2005). 
The skin over the left knee was sterilized twice with alcohol. 
The fur was removed with a hair razor. The knee was opened 
with a parapatellar medial incision and the tendon with the 
patella was dislocated laterally. The articulating cartilage was 
osteotomized with bone scissors from the distal femur, with 
the proximal tibia including the menisci and cruciate liga-
ments protecting the collateral ligaments. A 2-mm-wide and 
a 10-mm-deep hole was bored with a hand drill into the femur 
and tibia to fit the joint components. The joint capsule and skin 
were closed with Ethibond 4-0 and Vicryl 5-0 after placement 
of the knee prosthesis (press-fit model) without bone cement. 
Prosthesis
A rat-sized, non-constrained knee prosthesis was used (Figure 
1) The femoral component was made from a metal alloy and 
the tibial component was milled from high-density polyethyl-
ene stock.
Infection process
The infection was initiated by direct injection of 10 µL of the 
appropriate S. aureus bacterial suspension into the medullary 
canals of the femur and tibia. The volume of the suspension 
fitted into the marrow hole. Afterwards the condylar prosthesis 
was inserted.
Radiographic evaluation
AP and lateral radiographs were taken on days 0 (OP), 7, 14, 
21, and 42. To assess development and progression of bone 
infection, a modified scoring system was used (Schmidmaier 
et al. 2006). The following 6 parameters were scored: (I) peri-
osteal reaction, (II) osteolysis, (III) soft-tissue swelling, (IV) 
deformity, (V) general impression or destruction, (VI) loos-
ening of the prosthesis, and (VII) sequestrum formation. The 
score for each of the first 5 parameters used a scale of 0 to 
4: 0 (absent), 1 (mild), 2 (moderate), 3 (severe). Parameter 
VI “loosening of the prosthesis” was judged as 0 (none), 1 (1 
component), or 2 (both components), and parameter VII was 
judged as 0 (absent) or 1 (present). The maximum score that 
could be achieved was 18 (Figures 2 and 3).
Microbiological evaluation
The prosthesis components were explanted and rolled over 
non-selective  media  (5%  Danish  blood  agar  and  chocolate 
agar plates (State Serum Institute, Copenhagen, Denmark). 
Isolated  bacteria  were  identified  as  previously  described 
(Højby and Frederiksen 2000). The same procedure was used 
for bone from the femurs and tibias and for the synovialis, 
which were rolled over Danish blood agar and chocolate agar 
in 3 directions and incubated at 37°C. Bacterial growth was 
judged as no growth, growth in the first streak (+), growth in 
the first 2 streaks (++), or growth in all 3 streaks (+++). 
Table 1. Inoculum, ica:tet status, and strain
Group  n  Inoculum (CFU)  ica status  Strain
Control  5  0     ÷
G1  3  102  +  MN8
G2  9  103  +  MN8
G3  4  103  –  MN8
G4  11  ≥ 104  +  MN8
G5  3  102  +  UAMS-1
G6  6  103  +  UAMS-1
G7  4  103  –  UAMS-1
G8  9  ≥ 104  +  UAMS-1
Figure  1.  Non-constrained 
knee prosthesis.  94  Acta Orthopaedica 2013; 84 (1): 92–97
Bone and soft-tissue histology (Figure 4)
After removal of the prosthesis, the remnants of the tibia, 
femur, and synovialis were fixed in 4% buffered paraformal-
dehyde and decalcified in 10% formic acid/EDTA for 7 days. 
Samples were embedded in paraffin and transverse sections 
of 5 µm, including the implantation site, were cut on a micro-
tome. The sections were stained with hematoxylin and eosin. 
For the first 30 rats, histological analysis of tissues from the 
blood, liver, and spleen was also carried out. 
Semiquantitative scoring of all specimens was performed 
blind by pathologists who were not aware of the treatment 
groups (SSP and BMN). 
For histological scoring of severity of inflammation, trans-
verse  sections  of  the  tibia  and  femur  (with  the  prosthesis 
removed) and tissue from the synovialis were investigated. 
Each of the 3 tissues (femur, tibia, and synovialis) was given 
a score ranging from 0 to 4, depending on the severity of 
inflammation. 0 meant no signs of inflammation, 1 was slight 
focal  accumulation  of  inflammatory  cells  (neutrophils),  2 
was a moderate but consistent inflammation in the transverse 
sections and/or moderate inflammation of the entire circum-
ference  around  the  cavity  after  prosthesis  removal,  3  was 
the start of formation of an abscess in the cavity, and 4 was 
abscess formation and destruction of bone material with the 
synovialis completely infiltrated by neutrophils. The scores 
from the 3 separate tissues were added, giving a maximum 
score of 12.
Biochemical analysis
α-1  acid  glycoprotein  (AGP)—an  acute-phase  protein—
was measured on days 0 (preoperatively), 7, 14, 21, and 42 
(normal range: 0–130) (Matsumoto et al. 2007). Hemoglobin 
and leucocytes were also measured. There were no differences 
in the groups before and after the operation, irrespective of the 
bacterial strain and the infectious dose used. 
Clinical evaluation
Body  weight  and  temperature  were  determined,  and  well-
being  of  the  animal  was  estimated  using  food  intake  as  a 
parameter . Macroscopic judgement of the knee was scored 
as described previously (Petty et al. 1988). Briefly , normal = 
0, moderate swelling and edema = 0.5, swelling and abscess = 
1.0, and abscess and illness of the animal = 1.5. If abscesses 
and/or fistulae were present, pus was aspirated and cultured 
on blood agar plates, and any bacteria were identified (Høiby 
2000).
Statistics
All results are expressed as means. They were analyzed using 
the Kruskall-Wallis test for one-way analysis of variance. Sta-
tistical calculations were performed using SPSS for Windows 
software version 12.2. All p-values less than 0.05 were consid-




No osteolysis or signs of inflammation were seen in any of the 
radiographs in the control group, including loosening of the 
prosthesis (Figure 1). Radiographic changes in groups G1 and 
G5 (rats injected with 102 bacteria) indicated slight inflamma-
tion with little osteolysis and no loosening of the prosthesis. 
The modified scores (Schmidmaier et al. 2006) after 1 and 2 
weeks were 2.9 and 3.6, respectively. Radiographs from most 
rats in groups G2 and G6 (injected with 103 bacteria, ica+) 
showed  slight  to  moderate  inflammation  with  osteolysis,  a 
periosteal reaction, and soft-tissue swelling but the prosthesis 
remained in situ. The scores for G2 were 1.4 and 5.6 after 1 
and 2 weeks, respectively, and for G6 they were 0 and 5.3 after 
1 and 2 weeks, respectively. The rats infected with 103 CFU 
of the 2 different ica+ S. aureus strains MN8 and UAMS-1 
Figure 2. Prosthesis in situ without osteoly-
sis or bone destruction. Control group
Figure  4.  Severe  inflammation  with  intramedullary 
abscess in the femur (score = 8). 
Figure  3.  Severe  inflammation  with 
loosening of the prosthesis and bone 
destruction. S. aureus strain MN8, 104 
CFU (score = 13).Acta Orthopaedica 2013; 84 (1): 92–97  95
(groups G3 and G7) had the same level of virulence as judged 
from the same scores of 7.4 and 5.5 after 2 weeks, respec-
tively. The radiographic images of most rats in groups G4 and 
G8 (injected with > 104  ica+ S. aureus MN8 or UAMS-1, 
respectively)  showed  moderate  to  severe  inflammation  and 
most of the prostheses had loosened or were no longer in place 
(n = 12). For G4, mean scores after 1 and 2 weeks were 5.0 
and 7.1, respectively, and for G8 mean scores of 7.2 and 7.8 
were measured after 1 and 2 weeks (Table 2). 
 
Microbiology
No bacteria were cultured from the control group; thus, the 
prostheses were sterile. In G1 and G5 inoculated (with 102 
CFU S. aureus), only 2 of 6 cultures obtained from the knees 
yielded a few colonies of S. aureus and these were seen only 
with the UAMS-1 strain. In G2 (wild-type strain MN8, 103 
CFU) 8 of 12 implant cultures had a moderate number of colo-
nies (++) and in G6 (wild-type strain UAMS-1, 103 CFU), all 
6 cultures were positive (++). In G3 (ica- S. aureus MN8, 103 
CFU), 3 of 4 cultures were positive at the ++ level. In G7 (ica- 
S. aureus UAMS-1, 103 CFU), all 4 cultures yielded colonies 
at the ++ level. In G4 and G8 (wild-type MN8 and wild-type 
UAMS-1, > 104 CFU), all cultures were positive for S. aureus 
at the +++ level. No bacteria could be cultured from spleen, 
liver, or blood.
Histopathology
The  histopathology  was  consistent  with  the  radiographic 
findings. No signs of inflammation were found in the control 
group. No histological signs of inflammation or bacteria were 
found in the liver, spleen, or blood in any of the groups. In the 
2 groups that were given an inoculum of 102 (G1 and G5), all 
histological sections showed minor bone inflammation around 
the prosthesis with little bone destruction. In G2 and G6 (wild-
type MN8 and wild-type UAMS-1 strains), the histopathology 
sections showed typical signs of bone inflammation (osteo-
myelitis) such as destruction of cortical and cancellous bone 
(osteolysis) and new bone formation. In G3 and G7 (the S. 
aureus ica-groups) the same findings were obtained but with 
less osteolysis. In G4 and G8 (wild-type MN8 and wild-type 
UAMS-1,  >  104  CFU),  there  were  massive  signs  of  bone 
infection with destruction and abscess formation. 4 rats were 
killed or died preoperatively because of aspiration (Table 3). 
The 2 groups infected with more than 104 CFU were treated as 
1 group for further analysis.
Biochemistry and blood leukocyte counts
In the control group, the preoperative AGP levels were < 200 
µg/mL. In G2 (wild-type MN8, 103 CFU), the AGP increased 
from a mean of 170 µg/mL to 542 µg/mL after 2 weeks, and 
then decreased to a mean of 424 after 4 weeks. In G6 (wild-
type UAMS-1, 103 CFU), the AGP increased from a mean of 
168 to 218 after 2 weeks. The rats cleared the infection after 
2 weeks. Hemoglobin and leucocyte levels were not statisti-
cally significantly different from those in the control group, 
and the biochemistry parameters after 2 weeks and the leuko-
cyte counts and hemoglobin levels were similar. Only the AGP 
parameter was relevant for measurement of inflammation. 
Clinical results
There  was  no  statistically  significant  difference  in  mean 
weight loss between the control group and the G1 to G3 (CFU 
≤ 103 and G5 to G7 rats. However, the weight loss in G4 and 
G8 rats given the highest dose (> 104 CFU) was higher than 
in the control group. There was no soft-tissue swelling around 
the knee in the groups given 102 CFU (G1 and G5). Body 
temperature was similar in the different groups.
Discussion
Various  experimental  animal  models  of  osteomyelitis  have 
been  developed  since  1884  when  Rodet  and  Lexer  (Rodet 
1885, Lexer 1894) demonstrated that osteomyelitis similar to 
Table 2. Radiographic scores
 Week  Group  Inoculum (CFU)  Strain  Mean score
1  Control  0    –  0.5
2  Control  0    –  2.6
1  G1  102  MN8  2.3
2  G1  102  MN8  3.2
1  G2  103  MN8  1.4
2  G2  103  MN8  5.6
1  G3  ica- 103  MN8   6.0
2  G3  ica- 103  MN8   7.4
1  G4  ≥ 104  MN8  5.0
2  G4  ≥ 104  MN8  7.1
1  G5  102  UAMS  3.2
2  G5  102  UAMS  4.0
1  G6  103  UAMS  0
2  G6  103  UAMS  5.3
1  G7  ica- 103  UAMS  6.0
2  G7  ica- 103  UAMS  5.5
1  G8  ≥ 104  UAMS  7.2
2  G8  ≥ 104  UAMS  7.8
Table 3. Histopathology scores
Group   n  Inoculum (CFU)  Mean score  Strain
      (0–12) 
Control   5     0.0 
G1   3     102   2.7  MN8
G2   6     103   5.4  MN8
G3   4     103 ica-neg   6.5  MN8
G4   11   ≥ 104    > 9  MN8
G5   3     104   5.7  UAMS-1
G6   6     103    5.3  UAMS-1
G7   4     103 ica-neg   7.2  UAMS-1
G8   8     104   > 9  UAMS-196  Acta Orthopaedica 2013; 84 (1): 92–97
that seen in humans could be created experimentally by injec-
tion of staphylococci to produce bone abscesses. Mader (1985) 
and Norden (1988), together with several other authors, dem-
onstrated that osteomyelitis could be induced in an implant 
model by injection of bacteria into the tibia and femur cavities 
using either rats or rabbits (Mader 1985, Rissing 1990, An et 
al. 2006). Osteomyelitis studies related to orthopedic implant 
and prosthetic joint infection have been conducted using vari-
ous animals such as rats (Zak et al. 1982, Rissing et al. 1985), 
rabbits (Nelson et al. 1990), dogs (Fokushima et al. 2005), 
and guinea pigs (Ofluoglu et al. 2007). The in vivo animal 
models of osteomyelitis have certain advantages, which have 
provided us with a clearer understanding of the osteomyelitis 
process and treatments. The limitations of the models were 
mostly due to differences in the immune systems of the ani-
mals, the non-physiological way the bacteria were inoculated 
into the animals, the short observation periods, and the high 
bacterial doses used (Mader 1985). Rats are the second most 
widely used animal for these studies, which is why we also 
used them. In addition, it is simple to evaluate the histological 
and microbiological bone processes in rats. Development of 
the surgical procedure and use of loop-glasses and a specially 
designed small non-constrained knee prosthesis allows evalu-
ation of the osteomyelitis process in spite of the small size of 
the animal.
In most osteomyelitis models, lesions are induced by scle-
rosing agents, arachidonic acid, and foreign bodies contain-
ing bacteria to facilitate bone infection. Nelson et al. (1990) 
and Fukushima et al. (2005) did not use sclerosing agents 
and foreign bodies in their rat osteomyelitis models. They 
infected  the  animals  with  a  combination  of  Pseudomonas 
aeruginosa and S. aureus. Fukushima et al. (2005) examined 
the relationship between the inoculating dose of bacteria and 
the progression of osteomyelitis, and found that development 
of significant histological and radiographic signs of osteomy-
elitis required inocula of at least 6 × 103 CFU. Other authors 
have used foreign-body implants such as stainless steel pins 
and K-wires implanted into the bone marrow together with the 
bacteria to study the osteomyelitis process (Hudetz et al. 2008, 
Li et al. 2008). 
In our rat model the foreign body was implanted as a knee 
prosthesis, to mimic the human condition in which the osteo-
myelitis process is initiated in the bone marrow around the 
prosthesis. Osteomyelitis was seen after 1 week; it was local-
ized to the primary infected area without spreading to the 
liver, spleen, or blood. We found that inoculation of at least 
103 CFU of 2 wild-type S. aureus isolates resulted in signifi-
cant histological, bacteriological, and radiographic signs of 
osteomyelitis with loosening of the prostheses. Smeltzer et al. 
(1997) found that development of radiographic and histologic 
signs of osteomyelitis required inocula of at least 104 CFU. 
They used the same strain as we used (UAMS-1). We also 
found that the prosthesis remained in situ with an inoculum 
of 103 CFU, but the prosthesis was expelled after inoculation 
with > 104 CFU (for either S. aureus strain). For both MN8 
and UAMS-1, 103 CFU was the optimal inoculum for study of 
the osteomyelitis process around the prostheses.
The ica gene is a major operon for expression of a potential 
virulence factor, a polysaccharide involved in staphylococcal 
biofilm formation (PNAG). However, the role of biofilms in 
staphylococcal bone infection is still unclear (Knobben et al. 
2007), and they may not require the PNAG polysaccharide 
for formation. Both of the ica-strains gave rise to osteomy-
elitis that was no different to that achieved with the wild-type 
strains at the same size of inoculum (Table 2 ). Hudetz et al. 
(2008) found that the presence of ica genes had a strong effect 
on biofilm formation in vitro and a weak effect in vivo.
Overall, it appears that S. aureus causes persistent infec-
tion in a knee prosthesis implanted into rats, requiring a small 
number of bacteria. The tissue pathology and infection were 
independent of the presence of the ica genes and PNAG-
dependent biofilm formation. We have also shown that after 
2  weeks,  the  rats  can  clear  the  inflammation  with  doses 
between 103 and 105, indicating that it is not possible to study 
the  course  of  inflammation  for  longer  time.  The  immune 
system of the rat is quite different from the human immune 
system, which may explain their ability to clear the infec-
tion after injection of such relatively high doses. Even so, our 
study shows that a dose of 103 CFU of S. aureus would be a 
suitable experimental condition with which to study active 
and passive immunization against S. aureus in the same knee 
prosthesis model.
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